OncoTherapy Science Inc

30O

Company Profile

  • Business description

    OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.

  • Contact

    11th Floor, Kanagawa Science Park R&D
    3-2-1 Sakado
    Kanagawa
    Kawasaki213-0012
    JPN

    T: +81 448208251

    http://www.oncotherapy.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 March 2026

    Employees

    53

Stocks News & Analysis

stocks

Insignia Financial: Revised deal still attractive

The offer price is well above our fair value.
stocks

Undervalued ASX income play

Major development projects remain on schedule.
stocks

Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?

With the monetization of GenAI, here’s what we think of Alphabet’s stock

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,001.4059.900.67%
CAC 407,837.2392.821.20%
DAX 4024,168.95127.050.53%
Dow JONES (US)44,647.69145.250.33%
FTSE 1009,066.8143.000.48%
HKSE25,538.07408.041.62%
NASDAQ20,903.2610.570.05%
Nikkei 22541,171.321,396.403.51%
NZX 50 Index12,794.0639.68-0.31%
S&P 5006,323.7014.080.22%
S&P/ASX 2008,737.2060.000.69%
SSE Composite Index3,582.300.440.01%

Market Movers